Overexpression of Kynurenine 3-Monooxygenase Correlates with Cancer Malignancy and Predicts Poor Prognosis in Canine Mammary Gland Tumors

Figure 2

Expression level of the IDO gene in CMTs. (a) IDO gene expression in benign and malignant CMT tissues. (b) IDO gene expression in canine malignant CMTs at stages I/II/III and stages IV/V.

(a)

(b)